Active management of the third stage of labor: Uterine Tonus Assessment by Midwife vs. Patient self-administration - Trial PACTR201402000736158
Access comprehensive clinical trial information for PACTR201402000736158 through Pure Global AI's free database. This Not Applicable trial is sponsored by Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht; Korle Bu Teaching Hospital and is currently Recruiting. The study focuses on Pregnancy and Childbirth; Other.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht; Korle Bu Teaching Hospital
Korle Bu Teaching Hospital; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht
Timeline & Enrollment
Not Applicable
Jan 01, 1900
Jan 01, 1900
Summary
Rationale: Postpartum haemorrhage (PPH) is the most common cause of maternal death worldwide. The active management of the third stage of labour (AMTSL) is recognized as an effective strategy to prevent morbidity and mortality associated with PPH and reduce blood loss. AMTSL includes the provision of uterotonic drugs, controlled cord traction, delayed cord clamping and cutting, massage of the uterus, and monitoring of the uterine tonus. Although professional guidelines recommend the steps of AMTSL to be performed by health professionals, the reality of hospital understaffing in many low- and middle income countries (LMICs) necessitates task-shifting of the final AMTSL component to patients. Yet, whether uterus tonus assessment yields the same effect when performed by patients and midwives has not been formally evaluated. Objective: To determine whether there is a difference in effectiveness of routine uterine tonus assessment (every 15 minutes, for 2 hours) when performed by a midwife or self-administered by a patient on the incidence of postpartum hemorrhage. mean blood loss, and other maternal and neonatal outcomes.
ICD-10 Classifications
Data Source
Pan Africa Clinical Trials Registry
PACTR201402000736158
Non-Device Trial

